The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb
about
GRIN: "GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: an assessor-masked randomised comparison trial": study protocol.The Intra- and Inter-Rater Reliability of an Instrumented Spasticity Assessment in Children with Cerebral PalsyEvaluating Functional Outcomes of Botulinum Toxin Type A Injection Combined with Occupational Therapy in the Upper Limbs of Children with Cerebral Palsy: A 9-Month Follow-Up from the Perspectives of Both Child and Caregiver.Effectiveness and safety of botulinum toxin type a in children with musculoskeletal conditions: what is the current state of evidence?Static balance and function in children with cerebral palsy submitted to neuromuscular block and neuromuscular electrical stimulation: study protocol for prospective, randomized, controlled trialQuestionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.Influence of botulinum toxin therapy on postural control and lower limb intersegmental coordination in children with spastic cerebral palsySafety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study.Virtual Normalization of Physical Impairment: A Pilot Study to Evaluate Motor Learning in Presence of Physical Impairment.Botulinum toxin A treatment of the lower extremities in children with cerebral palsy.Effects of botulinum toxin type A on expression of genes in keloid fibroblasts.Use of botulinum toxin A in management of children with cerebral palsy.Botulinum Toxin in Pediatric Neurology: Switching Lanes From Death to Life.The use of botulinum toxin and epidural analgesia for the treatment of spasticity and pain in a patient with maple syrup urine disease.AbobotulinumtoxinA (Dysport®) Improves Function According to Goal Attainment in Children With Dynamic Equinus Due to Cerebral Palsy.Passive muscle properties are altered in children with cerebral palsy before the age of 3 years and are difficult to distinguish clinically from spasticity.Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.[Evaluation of a program of application of the botulinum toxin type A in children with cerebral palsy in Vale do Jequitinhonha].Long-Term Safety and Efficacy of Botulinum Toxin A Treatment in Adolescent Patients with Axillary Bromhidrosis.A low initial botulinum toxin A treatment response does not predict poor long-term outcomes in patients with axillary bromhidrosis.Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A.
P2860
Q35087305-36423E37-B30D-4F0B-982B-B5D3A09D4201Q35680834-21DD3764-6E4D-46A6-853C-A2F9CBD635F0Q35849535-B3E74CDB-1618-470A-9B18-054D3E6E46CBQ35893565-ABCDD70B-F701-4538-8938-235168B18284Q36124746-78581B6B-F46C-4C0D-AB89-0CD4B4DCB852Q36329606-BB18A064-D31A-4F1A-A274-3EE22D4D5E80Q36586751-CC4F38DD-B665-4EB3-B1DA-1306612A26BBQ36993876-2078AFE4-1CCC-4DE1-8E06-87CB1B7F6173Q37337395-A9CC07AD-AD50-45FF-B7FE-5E2129EE2CBCQ37715469-CB1AD4BB-8582-48C4-8E3B-AC4F0392F61EQ38178982-1A9A0102-8B26-439E-9A40-A962E8C8007DQ38315252-57EFFDAE-C0D0-440D-9C7B-FFAEC44D085FQ38428227-9336102E-F2C9-4F89-944A-FCBED5E4E73BQ38874264-3B6BB01E-CE6D-41F6-8833-CE08DEF02C7AQ42218063-1A7AFA65-D403-44A4-B417-124C3949DF08Q42290456-3AE25FB8-8EA5-485F-9414-8AC6FCBE5D9AQ43721809-A2677C22-989F-4453-95E3-041B9C63DEF3Q44106645-5357EDE3-473E-4CC6-AEBE-4A8236F0726FQ45763396-E11D65BD-D732-4B4F-84E3-CC9C71ED63ABQ49981404-77BBDC0B-02A3-4B8C-B024-8EDC9BC0F3A2Q50645015-46908A29-5128-4506-B6A2-F263119E66BEQ53435455-83AA7547-AD90-4562-B7BB-B88302FFB128
P2860
The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of botulinum toxin A i ...... with a focus on the lower limb
@en
The use of botulinum toxin A i ...... ith a focus on the lower limb.
@nl
type
label
The use of botulinum toxin A i ...... with a focus on the lower limb
@en
The use of botulinum toxin A i ...... ith a focus on the lower limb.
@nl
prefLabel
The use of botulinum toxin A i ...... with a focus on the lower limb
@en
The use of botulinum toxin A i ...... ith a focus on the lower limb.
@nl
P2093
P2860
P1476
The use of botulinum toxin A i ...... with a focus on the lower limb
@en
P2093
Anja Van Campenhout
Guy Molenaers
Jos De Cat
Katrien Fagard
P2860
P2888
P304
P356
10.1007/S11832-010-0246-X
P577
2010-03-18T00:00:00Z